Sarepta Therapeutics Inc. said another patient has died from acute liver failure after receiving one of its gene therapies, putting additional pressure on the biotech company after the recent deaths of two teenage boys.
www.bloomberg.com
#Sarepta #Patient #Died #Receiving #Gene #Therapy
More issuers are dropping Mizuho Securities Co. from bond underwriting roles after the Securities and Exchange Surveillance Commission began investigating…
Tony He, CFO of the Chinese biopharmaceutical firm 3SBio, discusses his outlook for dealmaking and the progress of a record…
Thai Prime Minister Paetongtarn Shinawatra’s fate remains uncertain after opposition calls and street protests for her to resign following a…
